findmyKOL
Clinical trialNCT04935684RecruitingPhase 2Interventional

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

SponsorUniversity Hospital, Clermont-FerrandEnrollment150Acute Leukemia in RemissionChronic Lymphocytic LeukemiaHodgkin LymphomaLymphoma, Non-HodgkinMyelodysplastic SyndromesMyeloma+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jacques-Olivier BAY, MD, PhD

    University Hospital, Clermont-Ferrand

    Principal Investigator
  • Stéphanie NGUYEN, MD, PhD

    Groupe hospitalier Pitié-Salpêtrière, Paris

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Service D'Hématologie Clinique Et Thérapie Cellulaire Chu Amiens Picardie - Site Sud

    Amiens, France

    Magalie Magalie, MD
    Not, yet, recruiting
  • Service Maladies Du Sang Chu Angers

    Angers, France

    Sylvie François, MD
    Not, yet, recruiting
  • Hématologie Clinique Chu Besançon

    Besançon, France

    Etienne Daguindau, MD
    Not, yet, recruiting
  • Plateforme D'Investigation Clinique / Centre D'Investigation Clinique - Inserm 1405, Chu Gabriel Montpied Clermont-Ferrand

    Clermont-Ferrand, France

    Christian Dualé, MD, PhD
    Recruiting
  • Service de Thérapie Cellulaire Et D'Hématologie Clinique Adulte Chu Estaing - Clermont-Ferrand

    Clermont-Ferrand, France

    Aurélie Ravinet, MDJacques-Olivier Bay, MD, PhD
    Not, yet, recruiting
  • Service Hématologie Chu Grenoble

    Grenoble, France

    Claude-Eric Bulabois, MD
    Not, yet, recruiting
  • Service Des Maladies Du Sang Hôpital Huriez, Chru de Lille

    Lille, France

    David Beauvais, MD
    Not, yet, recruiting
  • Service de Thérapie Cellulaire Et L'Hématologie Clinique Adulte Chu Limoges

    Limoges, France

    Pascal Turlure, MD
    Not, yet, recruiting
  • Service D'Hématologie Centre Hospitalier Lyon Sud

    Lyon, France

    Marie-Virginie Larcher, MD
    Not, yet, recruiting
  • Service D'Hématologie Et de Médecine Interne Hôpital Brabois Chru Nancy

    Nancy, France

    Marie-Therese Rubio, MD
    Not, yet, recruiting
  • Service D'Hématologie Clinique Chu Nantes

    Nantes, France

    Patrice Chevallier, MD
    Not, yet, recruiting
  • Service D'Hématologie Clinique, Département de Greffe de Moelle Chu Nice

    Nice, France

    Michel Loschi, MD
    Not, yet, recruiting
  • Service D'Hématologie Adultes Hôpital Necker

    Paris, France

    Ambroise Marçais, MD
    Recruiting
  • Service D'Hématologie Clinique Hôpital Pitié-Salpêtrière

    Paris, France

    Stéphanie Nguyen, MD, PhD
    Not, yet, recruiting
  • Service D'Hématologie Greffe Hôpital St Louis

    Paris, France

    Marie Robin, MD
    Not, yet, recruiting
  • Hématologie Clinique Et Thérapie Cellulaire Hôpital Haut-Lévèque

    Pessac, France

    Carmen Botella Garcia, MD
    Not, yet, recruiting
  • Service D'Hématologie Greffe Hôpital St Louis

    Poitiers, France

    Deborah Desmier, MD
    Not, yet, recruiting
  • Département D'Hématologie Cac Rouen

    Rouen, France

    Anne-Lise Menard, MD
    Not, yet, recruiting
  • Hématologie Clinique Institut de Cancérologie de la Loire

    Saint-Etienne, France

    Emmanuelle Tavernier, MD
    Not, yet, recruiting
  • Iuc T - Oncopôle

    Toulouse, France

    Anne Huynh, MD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Dec 2022
Primary completion
31 May 2030
Completion
31 May 2030
Last update posted
9 Jun 2026
Registered enrollment
150
Registry id
NCT04935684

Cross-registrations

EU-CTR / CTIS (EudraCT)2020-000673-24

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.